Taiwan Primo Biotechnology Co., Ltd.
Update：2025/12/24
Industries
Main Industry
Health Care
Main Product/Service
Primo’s products and services include radioligand therapeutic agents, tumor‑molecular imaging diagnostics (such as PB01 / [¹⁸F]PSMA‑1007 for prostate cancer), and imaging‑platform plus manufacturing services supporting clinical trials. The company has als
Founded Year
2021
Unified Business No.
90712775
Status
Active
Number of Employees
0
Total Paid-in
Capital
584,760,228 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Primo Biotechnology Co., Ltd., headquartered in Taipei, focuses on the development and manufacturing of precision medicine and radioligand theranostics (RLT). The company is committed to leveraging molecular imaging and radiopharmaceutical technologies to
